htlr8 (InvivoGen)
InvivoGen is a verified supplier 
InvivoGen manufactures this product 
95
Structured Review
InvivoGen
htlr8
Htlr8, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 130 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htlr8+cells/HEK-Blue+hTLR9+cells/pm41962328-330-16-21
Average 95 stars, based on 130 article reviews
Htlr8, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 130 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htlr8+cells/HEK-Blue+hTLR9+cells/pm41962328-330-16-21
Average 95 stars, based on 130 article reviews
htlr8 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Control:Article Title: Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability Article Snippet: .. HEK-BlueTM mTLR7, mTLR8, hTLR7, and Article Title: Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability. Article Snippet: .. HEK-BlueTM mTLR7, mTLR8, hTLR7, and Cell Culture:Article Title: Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability Article Snippet: .. HEK-BlueTM mTLR7, mTLR8, hTLR7, and Article Title: Strategic Development of a Self-Adjuvanting Sars-Cov-2 Rbd Vaccine: From Adjuvant Screening to Enhanced Immunogenicity with a Modified Tlr7 Agonist Article Snippet: Analysis of the final RBD-MT conjugate by MALDI-TOF mass spectrometry indicated that molecule covalently links with the RBD. .. 2.8 TLR reporter assay HEK-Blue hTLR7 and Article Title: The novel selective TLR7 agonist GY101 suppresses colon cancer growth by stimulating immune cells. Article Snippet: Toll-like receptor (TLR) 7, a transmembrane signal transduction receptor expressed on the surface of endosomes, has become an attractive target for antiviral and cancer immunotherapies.. TLR7 can induce signal transduction by recognizing single-stranded RNA or its analogs, leading to the release of cytokines such as IL-6, IL-12, TNF-α and type-I IFN.. Activation of TLR7 helps to enhance immunogenicity and immune memory by stimulating immune cells. Article Title: Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability. Article Snippet: .. HEK-BlueTM mTLR7, mTLR8, hTLR7, and Article Title: Strategic development of a self-adjuvanting SARS-CoV-2 RBD vaccine: From adjuvant screening to enhanced immunogenicity with a modified TLR7 agonist. Article Snippet: Adjuvants enhance the body’s immune response to a vaccine, often leading to better protection against diseases.. Monophosphoryl lipid A analogues (MPLA, TLR4 agonists), α-galactosylceramide analogues (NKT cell agonists), and imidazoquinoline compounds (TLR7/8 agonists) are emerging novel adjuvants on market or under clinical trials.. Despite significant interest in these adjuvants, a direct comparison of their adjuvant activities remains unexplored. Activity Assay:Article Title: Strategic Development of a Self-Adjuvanting Sars-Cov-2 Rbd Vaccine: From Adjuvant Screening to Enhanced Immunogenicity with a Modified Tlr7 Agonist Article Snippet: 2.8 TLR reporter assay HEK-Blue hTLR7 and hTLR8 cells (InvivoGen) were cultured in DMEM supplemented with 10% FBS, Penicillin-Streptomycin (Beyotime), blasticidin (InvivoGen), zeocin (InvivoGen) and normocin (InvivoGen). .. HEK-Blue hTLR7 cells were harvested and mixed with HEK-BlueTM Detection (InvivoGen), the mixture was distributed into 96 well plates at 2.5×104 cells/well then treated with DMSO, TLR7/8 or compound 6 at different concentrations (0.0001 μM, 0.001 μM, 0.01 μM, 0.1 μM, 1 μM) for 14 h. HEK-Blue Article Title: Strategic development of a self-adjuvanting SARS-CoV-2 RBD vaccine: From adjuvant screening to enhanced immunogenicity with a modified TLR7 agonist. Article Snippet: Adjuvants enhance the body’s immune response to a vaccine, often leading to better protection against diseases.. Monophosphoryl lipid A analogues (MPLA, TLR4 agonists), α-galactosylceramide analogues (NKT cell agonists), and imidazoquinoline compounds (TLR7/8 agonists) are emerging novel adjuvants on market or under clinical trials.. Despite significant interest in these adjuvants, a direct comparison of their adjuvant activities remains unexplored. Reporter Assay:Article Title: Strategic Development of a Self-Adjuvanting Sars-Cov-2 Rbd Vaccine: From Adjuvant Screening to Enhanced Immunogenicity with a Modified Tlr7 Agonist Article Snippet: Analysis of the final RBD-MT conjugate by MALDI-TOF mass spectrometry indicated that molecule covalently links with the RBD. .. 2.8 TLR reporter assay HEK-Blue hTLR7 and |